Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on November 18, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Roche Cobas 6000 Reagents, Consumables and Preventative Maintenance Services

Closed
25-000204Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413
New
Federal
Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.
Solicitation # 36C26027Q0058
The Department of Veterans Affairs, through Network Contracting Office 20, is seeking a comprehensive histology staining workflow system for the Puget Sound Health Care System in Seattle, Washington. The required system must include two immunohistochemistry and two in-situ hybridization immunostainers, two special stainers, and an integrated specimen tracking system to ensure patient safety, maintain a chain of custody, and monitor productivity. The workflow components must be fully automated, communicate with one another, and maintain compatibility with Data Innovations middleware as well as VISTA, Cerner, and any future electronic health record systems acquired by the VA. The contract follows a Cost Per Reportable Result pricing model and spans a base year from February 1, 2027, to January 31, 2028, with four subsequent one-year option periods extending through January 31, 2032. Technical requirements specify that the immunostainers must perform 100% of tests listed in the provided specifications and support simultaneous IHC, ISH, and Direct Immunofluorescence staining. Equipment must support Code 39 and Code 128 barcodes, include a safe hazardous waste removal system, and be provided with an uninterruptible power supply capable of supporting a 15-minute controlled shutdown. The contractor is responsible for the delivery, installation, and removal of equipment at no additional charge and must guarantee a minimum equipment uptime of 98%. Performance and method validation must adhere to CLSI guidelines and College of American Pathologists standards. Additionally, the contractor must comply with strict federal and VA information security directives, including those regarding data confidentiality and media sanitization. Emergency supply orders must be fulfilled within 24 hours of a verbal request, providing enough consumables for one week of normal operation.
260-NETWORK Contract Office 20 (36C260)

POSTED

2 days ago

DEADLINE

in 23 days
NAICS: 325413
New
Federal
6550--HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Solicitation # 36C26227Q0046
The Department of Veterans Affairs, Network Contracting Office 22, is conducting a sources sought notice for the procurement of FDA approved reagents, supplies, consumables, and quality control materials for Werfen Hemochron Signature Elite instruments. This requirement supports the Pathology and Laboratory Medicine Service at the Southern Arizona VA Health Care System in Tucson, Arizona. The contract structure includes a base year from January 1, 2027, to December 31, 2028, followed by four subsequent option years extending through December 31, 2032. The selected contractor must provide 24/7 technical and product support at no additional cost and ensure all items are fully compatible with existing instrumentation without requiring workflow changes or retraining. Key operational requirements include strict adherence to manufacturer specifications for packaging and temperature control during transport. All supplied materials must maintain a minimum shelf life of 90 days, and shipments must clearly list lot numbers and expiration dates. Standard orders are required to be delivered within four working days, while emergency deliveries for defective or temperature-compromised items must be completed within 24 hours of a verbal order. This procurement is conducted as a brand name or equal acquisition under FAR 52.211-6. Interested respondents must provide their business size status, SAM.gov identifiers, and evidence of compliance with the Buy American Act and the Non-Manufacturer Rule.
262-NETWORK Contract Office 22 (36C262)

POSTED

3 days ago

DEADLINE

in 13 days

General Info

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health - Cc
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more
THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY. It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a solicitation will not receive a response. Responses to this sources sought must be in writing. The purpose of this sources sought announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Small Businesses interested and capable of providing the services described below. The information gained from this market research will help the National Institutes (NIH), Clinical Center, Department of Laboratory Medicine plan for its acquisition strategy. Potential Large and Small Businesses shall include business information outlined in the section below as a part of their response. POTS: 25-000204 Complete responses to this notice shall be in the following format: SAM UEI Number Company Name Company Address, City, State and Zip Code Company Point of Contact, Email Address and Telephone Number Current GSA Schedule appropriate to this Sources Sought Socioeconomic Status: (i.e., HUBZone, 8a, Small Business, Women Owned Small Business, Veteran-Owned Small-Business, etc.) as validated in Central Contractor Registration (CCR). All offerors must register in CCR located in https://www.sam.gov. Provide a capability statement that addresses the organizations qualifications and ability to perform as a contractor for the work described in the Statement of Work. ***************************************************************************** The National Institutes of Health, Clinical Center, Department of Laboratory Medicine has a requirement for a contractor to provide Roche Cobas 6000 Reagents, Consumables and Preventative Maintenance Services. The Department of Laboratory Medicine, Immunoassay Section has a continued need for Roche reagents, consumables, and preventative maintenance services. The Roche Cobas 6000 System can only use Roche proprietary reagents and consumables. The Roche Cobas 6000 is an excellent robust instrument providing reliable results and performance along with an excellent maintenance service record. The large test menu provides state of the art laboratory testing necessary to support the Clinical Center for patient care and research testing providing high volume needs as well as rapid turnaround times for clinical testing. The Department of Laboratory Medicine, Immunoassay Section owns one (1) Roche Cobas 6000 system used to perform forty (40) chemistry and immunoassay tests for the monitoring of patient care, diagnosis of various diseases, and research protocols. Some of the tests includes: The core test menu consists of ACE, Free Fatty Acids, Cancer Antigen 15-3, Cancer Antigen 19-9, C-Peptide, Insulin, Osteocalcin, Parathyroid Hormone, Rubella IgG, Toxoplasma IgG, Pro-BNP, CKMB, Cystatin-C, SARS-CoV-2 anti-N, SARS-CoV-2 anti-S, Albumin, Alkaline Phosphatase, Alanine Transaminase, Amylase, Aspartate Aminotransferase, Blood Urea Nitrogen, Direct Bilirubin, Calcium, Chloride, Cholesterol, Creatine Kinase, Creatinine, Carbon Dioxide, Glucose, Lactate Dehydrogenase, Magnesium, Potassium, Sodium, Phosphorus, Total Bilirubin, Total Protein, Triglycerides, Uric Acid, Serum Indices. Period of Performance: 02/01/2025 to 01/31/2026. Delivery Schedule: Reagents and consumables will be delivered on an as needed Basis. Preventative maintenance and repair services will be performed by an authorized and trained service technician in accordance with the original manufacturer recommendations. Delivery Location: Deliver to: Attention: TBD National Institutes of Health 10 Center Drive Building 10, Room TBD Bethesda, MD 20892-1288 Contractors shall not reach out to the customer for any questions or clarifications. All communications must go through contracting. ****************************************************************************** Important information: The Government is not obligated to nor will it pay for or reimburse any costs associated with responding to this source sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. NAICS: The North American Classification System (NAICS) code for this acquisition is 325413- In Vitro Diagnostic Substance Manufacturing (Small Business Size Standards 1,250 Average Number of Employees) PSC: 6550- In Vitro Diagnostic Substances, Reagents, Test Kits and Sets Notice to potential offerors: All offerors who provide goods or services to the United States Federal Government must be registered and have an active registration in the System for Award Management (SAM) at www.sam.gov and complete Online Representations and Certifications Application (ORCA). All interested Offerors should submit information by e-mail to sheri.eiri@nih.gov All information submissions shall be received no later than 12:00 pm Eastern Standard Time, November 28, 2024.

More opportunities from Department Of Health And Human Services → National Institutes Of Health - Cc

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS